Screener
Madrigal Pharmaceuticals, Inc. MDGL PP&E (Net)
PP&E (Net) at other companies
Other financials
Where this comes from
Reported directly by Madrigal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.
The source filing: Madrigal Pharmaceuticals, Inc.’s 10-Q, filed July 30, 2026.
- Filed
- Jul 30, 2026, 9:06 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-050845
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Inventory | 99,391 | 74,841 |
| Prepaid expenses and other current assets | 68,570 | 47,804 |
| Total current assets | 1,199,180 | 1,245,770 |
| Property and equipment, net | 11,592 | 1,499 |
| Intangible assets, net | 7,187 | 7,381 |
| Operating lease right-of-use assets | 5,578 | 4,939 |
| Other noncurrent assets | 21,108 | — |
| Total assets | $1,244,645 | $1,259,589 |
Item 1. Financial Statements (Unaudited):
FAQ
- What is Madrigal Pharmaceuticals, Inc.'s PP&E (net)?
- Madrigal Pharmaceuticals, Inc. (MDGL) reported PP&E (net) of $11.59M in Q2 2026.
- How has Madrigal Pharmaceuticals, Inc.'s PP&E (net) changed year-over-year?
- Madrigal Pharmaceuticals, Inc.'s PP&E (net) increased by 617.8% year-over-year, from $1.62M to $11.59M.
- What is the long-term trend for Madrigal Pharmaceuticals, Inc.'s PP&E (net)?
- Over 5 years (2020 to 2025), Madrigal Pharmaceuticals, Inc.'s PP&E (net) has grown at a 7.4% compound annual growth rate (CAGR), from $1.05M to $1.5M.
- What does PP&E (net) mean?
- Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.
Ask your AI about Madrigal Pharmaceuticals, Inc.'s pp&e (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude